Zahra Kazemi

Title: Zahra Kazemi: Innovator in Stem Cell Transplantation

Introduction

Zahra Kazemi is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of stem cell transplantation, particularly in enhancing the efficacy of engraftment processes. Her innovative work has the potential to improve outcomes for patients undergoing such procedures.

Latest Patents

Zahra Kazemi holds a patent for a composition aimed at increasing the engraftment efficacy of hematopoietic stem cells after transplantation. The patent, titled "Composition for use in increasing engraftment efficacy of haematopoietic stem cells after transplantation," describes a novel use of a composition that includes at least one inhibitor of dipeptidyl peptidase IV (DPP-IV). This composition is designed to enhance the migration and homing of hematopoietic progenitor cells in recipients of stem cell transplants. The treatment involves using an engraftment enhancing compound, specifically a prostacyclin analog and a cAMP enhancer, prior to transplantation.

Career Highlights

Zahra Kazemi has established herself as a key figure in her field through her innovative research and development efforts. She is associated with Scipharm Sarl, where she continues to work on advancing stem cell therapies. Her dedication to improving medical outcomes through scientific research is evident in her patent and ongoing projects.

Collaborations

Zahra collaborates with notable colleagues, including Michael Freissmuth and Eva-Maria Zebedin-Brandl. These partnerships enhance her research capabilities and contribute to the advancement of stem cell transplantation techniques.

Conclusion

Zahra Kazemi's work in the field of stem cell transplantation exemplifies the impact of innovation in medicine. Her patent and collaborations highlight her commitment to improving patient care through scientific advancements.